Skip to content
AASLD Family of Websites: Liver Fellow Network
AASLD.org AASLD Foundation LiverLearning Career Center Journals The Liver Meeting HCV Guidelines
AASLD Logo
AASLD Logo

LFN Main Navigation

  • Topics
    Acute Liver Failure Alcohol-Associated Liver Disease Autoimmune Hepatitis Career Development and Mentorship Cholestatic Liver Disease Complications of Liver Disease and Portal Hypertension Drug-Induced Liver Disease HepMadness Inherited Disorders Liver Anatomy, Development, and Physiology Liver Infections Liver Physiology Liver Related Infections MASLD/MASH Neoplasms of the Liver Pathology Pediatrics Pregnancy-Related Liver Disease Symptoms and Clinical Presentation of Liver Disease and Portal HTN Systemic Conditions with Hepatic Manifestations Transplantation and Surgery Vascular Viral Hepatitis
  • Core Series
    Back to Basics Clinical Pearls Webinars Evidence Corner Pathology Pearls Podcast The Why? Series Tools of the Trade View All Core Series Guidelines Practice Questions
  • Tweetorials
  • About
  • Core Series
  • Evidence Corner
  • Should We Consider Using Aspirin In Patients With MASLD?

Should We Consider Using Aspirin in Patients with MASLD?

September 30, 2025

Emily Seltzer

Share

Copy Link Twitter Facebook

https://jamanetwork.com/journals/jama/fullarticle/2816236

MASLD/MASH

Share

Copy Link Twitter Facebook

Written By:

Emily Seltzer

Related Content

The Enhanced Liver Fibrosis Test is a Superior Blood-Based Predictor of Advanced Fibrosis in NAFLD patients < 65 years with Type II Diabetes

June 24, 2025

Aldafermin for the Management of Compensated MASH Cirrhosis: the ALPINE-4 Trial

February 9, 2024

Liver stiffness not steatotic liver disease is associated with atrial fibrillation

November 8, 2023

AASLD LFN Logo

Follow Us

Disclaimer & Privacy Policy

© 2025 American Association for the Study of Liver Diseases